TEVA logo

TEVA Total liabilities

annual total liabilities:

$33.61B-$1.75B(-4.94%)
December 31, 2024

Summary

  • As of today (May 29, 2025), TEVA annual total liabilities is $33.61 billion, with the most recent change of -$1.75 billion (-4.94%) on December 31, 2024.
  • During the last 3 years, TEVA annual total liabilities has fallen by -$2.82 billion (-7.73%).
  • TEVA annual total liabilities is now -42.12% below its all-time high of $58.06 billion, reached on December 31, 2016.

Performance

TEVA Total liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTEVAbalance sheet metrics

quarterly total liabilities:

$32.15B-$1.46B(-4.34%)
March 31, 2025

Summary

  • As of today (May 29, 2025), TEVA quarterly total liabilities is $32.15 billion, with the most recent change of -$1.46 billion (-4.34%) on March 31, 2025.
  • Over the past year, TEVA quarterly total liabilities has dropped by -$3.08 billion (-8.75%).
  • TEVA quarterly total liabilities is now -47.92% below its all-time high of $61.72 billion, reached on September 30, 2016.

Performance

TEVA quarterly total liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTEVAbalance sheet metrics

Total liabilities Formula

Total Liabilities = Current Liabilities + Long-Term Liabilities

TEVA Total liabilities Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-4.9%-8.8%
3 y3 years-7.7%-12.6%
5 y5 years-20.8%-21.1%

TEVA Total liabilities Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-7.7%at low-12.6%at low
5 y5-year-20.8%at low-21.1%at low
alltimeall time-42.1%>+9999.0%-47.9%>+9999.0%

TEVA Total liabilities History

DateAnnualQuarterly
Mar 2025
-
$32.15B(-4.3%)
Dec 2024
$33.61B(-4.9%)
$33.61B(-5.0%)
Sep 2024
-
$35.37B(+1.7%)
Jun 2024
-
$34.77B(-1.3%)
Mar 2024
-
$35.23B(-0.3%)
Dec 2023
$35.35B(-0.2%)
$35.35B(+2.2%)
Sep 2023
-
$34.58B(-2.3%)
Jun 2023
-
$35.39B(+1.6%)
Mar 2023
-
$34.84B(-1.6%)
Dec 2022
$35.41B(-2.8%)
$35.41B(+2.0%)
Sep 2022
-
$34.73B(-3.8%)
Jun 2022
-
$36.10B(-1.9%)
Mar 2022
-
$36.80B(+1.0%)
Dec 2021
$36.42B(-8.0%)
$36.42B(+0.1%)
Sep 2021
-
$36.40B(-3.9%)
Jun 2021
-
$37.88B(-0.4%)
Mar 2021
-
$38.03B(-3.9%)
Dec 2020
$39.58B(-6.7%)
$39.58B(+1.1%)
Sep 2020
-
$39.15B(-2.5%)
Jun 2020
-
$40.17B(-1.4%)
Mar 2020
-
$40.74B(-3.9%)
Dec 2019
$42.41B(-5.5%)
$42.41B(+0.2%)
Sep 2019
-
$42.32B(-4.2%)
Jun 2019
-
$44.17B(+0.3%)
Mar 2019
-
$44.03B(-1.9%)
Dec 2018
$44.89B(-13.5%)
$44.89B(-2.3%)
Sep 2018
-
$45.93B(-3.6%)
Jun 2018
-
$47.66B(-2.9%)
Mar 2018
-
$49.08B(-5.4%)
Dec 2017
$51.87B(-10.7%)
$51.87B(-7.0%)
Sep 2017
-
$55.79B(-1.7%)
Jun 2017
-
$56.75B(+2.2%)
Mar 2017
-
$55.53B(-4.4%)
Dec 2016
$58.06B(+138.9%)
$58.06B(-5.9%)
Sep 2016
-
$61.72B(+138.3%)
Jun 2016
-
$25.90B(+5.6%)
Mar 2016
-
$24.54B(+0.9%)
Dec 2015
$24.31B(+5.4%)
$24.31B(-5.5%)
Sep 2015
-
$25.73B(-5.7%)
Jun 2015
-
$27.29B(+12.4%)
Mar 2015
-
$24.27B(+5.2%)
Dec 2014
$23.07B(-7.3%)
$23.07B(+0.6%)
Sep 2014
-
$22.94B(-0.9%)
Jun 2014
-
$23.14B(-3.0%)
Mar 2014
-
$23.86B(-4.1%)
Dec 2013
$24.87B(-10.3%)
$24.87B(-2.3%)
Sep 2013
-
$25.46B(-1.7%)
Jun 2013
-
$25.89B(+2.5%)
Mar 2013
-
$25.25B(-9.0%)
Dec 2012
$27.74B(-0.2%)
$27.74B(+4.7%)
Sep 2012
-
$26.51B(+2.0%)
Jun 2012
-
$25.99B(-4.7%)
Mar 2012
-
$27.27B(-1.9%)
Dec 2011
$27.80B(+72.1%)
$27.80B(+51.6%)
Sep 2011
-
$18.34B(+11.8%)
Jun 2011
-
$16.41B(+1.8%)
Mar 2011
-
$16.12B(-0.2%)
Dec 2010
$16.15B
$16.15B(-6.8%)
Sep 2010
-
$17.33B(+9.5%)
Jun 2010
-
$15.82B(+10.1%)
DateAnnualQuarterly
Mar 2010
-
$14.37B(+3.0%)
Dec 2009
$13.95B(-15.7%)
$13.95B(-0.3%)
Sep 2009
-
$13.99B(-2.8%)
Jun 2009
-
$14.40B(-10.6%)
Mar 2009
-
$16.11B(-2.6%)
Dec 2008
$16.54B(+71.4%)
$16.54B(+64.0%)
Sep 2008
-
$10.09B(+1.9%)
Jun 2008
-
$9.90B(-2.9%)
Mar 2008
-
$10.20B(+5.7%)
Dec 2007
$9.65B(+3.9%)
$9.65B(+1.2%)
Sep 2007
-
$9.54B(-1.2%)
Jun 2007
-
$9.65B(+0.5%)
Mar 2007
-
$9.60B(+3.3%)
Dec 2006
$9.29B(+114.3%)
$9.29B(-1.0%)
Sep 2006
-
$9.39B(-0.4%)
Jun 2006
-
$9.43B(+3.4%)
Mar 2006
-
$9.12B(+110.4%)
Dec 2005
$4.34B(+2.5%)
$4.34B(+6.1%)
Sep 2005
-
$4.09B(-0.6%)
Jun 2005
-
$4.12B(-2.2%)
Mar 2005
-
$4.21B(-0.6%)
Dec 2004
$4.23B(+61.5%)
$4.23B(+6.0%)
Sep 2004
-
$3.99B(-6.3%)
Jun 2004
-
$4.26B(+0.0%)
Mar 2004
-
$4.26B(+62.6%)
Dec 2003
$2.62B(-6.2%)
$2.62B(-13.6%)
Sep 2003
-
$3.03B(+0.3%)
Jun 2003
-
$3.02B(+4.7%)
Mar 2003
-
$2.89B(+3.4%)
Dec 2002
$2.79B(+34.4%)
$2.79B(+24.6%)
Sep 2002
-
$2.24B(+1.9%)
Jun 2002
-
$2.20B(+6.6%)
Mar 2002
-
$2.06B(-0.6%)
Dec 2001
$2.08B(+22.0%)
$2.08B(+0.2%)
Sep 2001
-
$2.07B(+30.2%)
Jun 2001
-
$1.59B(-1.8%)
Mar 2001
-
$1.62B(-4.8%)
Dec 2000
$1.70B(+68.9%)
$1.70B(+34.0%)
Sep 2000
-
$1.27B(-2.7%)
Jun 2000
-
$1.31B(+34.4%)
Mar 2000
-
$971.20M(-3.7%)
Dec 1999
$1.01B(+29.8%)
$1.01B(-2.8%)
Sep 1999
-
$1.04B(+40.4%)
Jun 1999
-
$739.10M(-0.8%)
Mar 1999
-
$744.80M(-4.1%)
Dec 1998
$776.40M(+34.9%)
$776.40M(+2.3%)
Sep 1998
-
$759.20M(+18.1%)
Jun 1998
-
$643.00M(+19.4%)
Mar 1998
-
$538.50M(-6.4%)
Dec 1997
$575.60M(-18.5%)
$575.60M(-18.5%)
Dec 1996
$706.20M(+27.9%)
$706.20M(+27.9%)
Dec 1995
$552.20M(+65.5%)
$552.20M(+65.5%)
Dec 1994
$333.60M(+13.0%)
$333.60M(+13.0%)
Dec 1993
$295.10M(+33.0%)
$295.10M(+33.0%)
Dec 1992
$221.90M(+14.6%)
$221.90M(+14.6%)
Dec 1991
$193.70M(-7.0%)
$193.70M(-7.0%)
Dec 1990
$208.20M(+24.4%)
$208.20M(+24.4%)
Dec 1989
$167.30M(+12.3%)
$167.30M(+12.3%)
Dec 1988
$149.00M(+75.3%)
$149.00M(+75.3%)
Mar 1987
$85.00M(-4.7%)
$85.00M(-4.7%)
Mar 1986
$89.20M
$89.20M

FAQ

  • What is Teva Pharmaceutical Industries Limited annual total liabilities?
  • What is the all time high annual total liabilities for Teva Pharmaceutical Industries Limited?
  • What is Teva Pharmaceutical Industries Limited annual total liabilities year-on-year change?
  • What is Teva Pharmaceutical Industries Limited quarterly total liabilities?
  • What is the all time high quarterly total liabilities for Teva Pharmaceutical Industries Limited?
  • What is Teva Pharmaceutical Industries Limited quarterly total liabilities year-on-year change?

What is Teva Pharmaceutical Industries Limited annual total liabilities?

The current annual total liabilities of TEVA is $33.61B

What is the all time high annual total liabilities for Teva Pharmaceutical Industries Limited?

Teva Pharmaceutical Industries Limited all-time high annual total liabilities is $58.06B

What is Teva Pharmaceutical Industries Limited annual total liabilities year-on-year change?

Over the past year, TEVA annual total liabilities has changed by -$1.75B (-4.94%)

What is Teva Pharmaceutical Industries Limited quarterly total liabilities?

The current quarterly total liabilities of TEVA is $32.15B

What is the all time high quarterly total liabilities for Teva Pharmaceutical Industries Limited?

Teva Pharmaceutical Industries Limited all-time high quarterly total liabilities is $61.72B

What is Teva Pharmaceutical Industries Limited quarterly total liabilities year-on-year change?

Over the past year, TEVA quarterly total liabilities has changed by -$3.08B (-8.75%)
On this page